Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
US Army
Baxter
US Department of Justice
Colorcon
Argus Health
Daiichi Sankyo
McKinsey
Deloitte

Generated: April 26, 2018

DrugPatentWatch Database Preview

DECA-DURABOLIN Drug Profile

« Back to Dashboard

When do Deca-durabolin patents expire, and when can generic versions of Deca-durabolin launch?

Deca-durabolin is a drug marketed by Aspen Global Inc and is included in one NDA.

The generic ingredient in DECA-DURABOLIN is nandrolone decanoate. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nandrolone decanoate profile page.
Drug patent expirations by year for DECA-DURABOLIN
Synonyms for DECA-DURABOLIN
(17-beta)-17-((1-Oxodecyl)oxy)estr-4-en-3-one
(17beta)-3-oxoestr-4-en-17-yl decanoate
(1S,2R,10R,11S,14S,15S)-15-methyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-14-yl decanoate
(1S,2R,10R,11S,14S,15S)-15-methyl-5-oxotetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-6-en-14-yl decanoate
(1S,2R,10R,11S,14S,15S)-15-METHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-6-EN-14-YL DECANOATE
(8R,9S,10R,13S,14S,17S)-13-Methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl decanoate
[(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] decanoate
17-beta-Hydroxyestr-4-en-3-one decanoate
17b-[(1-oxodecyl)oxy]estr-4-en-3-one
17BETA-HYDROXY-19-NOR-4-ANDROSTEN-3-ONE 17-DECANOATE
17BETA-HYDROXY-4-ESTREN-3-ONE 17-DECANOATE
17beta-Hydroxyestr-4-en-3-one 17-decanoate
17beta-Hydroxyestr-4-en-3-one decanoate
17BETA-NANDROLONE DECANOATE
19-nor-4-androstene-17 beta-ol-3-one 17-decanoate
19-Norandrostenolone decanoate
19-NORTESTOSTERONE 17-DECANOATE
19-Nortestosterone decanoate
19-Nortestosterone-17.beta.-decanoate
19-Nortestoteronedecanoate
360-70-3
360N703
4-ESTREN-17BETA-OL-3-ONE 17-DECANOATE
4-ESTREN-17BETA-OL-3-ONE DECANOATE
AB03760
AC-1484
AC1L1TKM
Adenocorin
AK309978
AKOS025311438
AN-14913
Anabolin Depot
Anaboline Depot
Axedanin
BRN 2228051
C-22219
C08154
CAS-360-70-3
CC-32424
CHEBI:7467
CHEMBL1200946
CS-4613
CTK8D6788
D00955
DB08804
Deca Durabolin
Deca-Durabol
Deca-Durabolin (TN)
Deca-Durobolin
Deca-Hybolin
Decadurabolin
Decadurobolin
DECANOIC ACID 13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHE
Dimapolan
DRG 0264
DSSTox_CID_3352
DSSTox_GSID_23352
DSSTox_RID_76988
DTXSID7023352
EINECS 206-639-3
Estr-4-en-3-one, 17-((1-oxodecyl)oxy)-, (17beta)-
Estr-4-en-3-one, 17-[(1-oxodecyl)oxy]-, (17.beta.)-
Estr-4-en-3-one, 17-[(1-oxodecyl)oxy]-, (17b)-
Estr-4-en-3-one, 17-beta-hydroxy-, decanoate
GS-3155
H45187T098
HY-13698
Hybolin decanoate
JKWKMORAXJQQSR-MOPIKTETSA-N
LP086471
LS-64854
LT01138619
MFCD00135100
MolPort-006-111-246
naboline
Nandrobolic L.A
Nandrolone 17beta-decanoate
NANDROLONE DECANOATE
Nandrolone decanoate (JAN/USP)
Nandrolone decanoate [USAN:JAN]
Nandrolone decanoate for peak identification, European Pharmacopoeia (EP) Reference Standard
Nandrolone decanoate for system suitability, European Pharmacopoeia (EP) Reference Standard
Nandrolone decanoate, European Pharmacopoeia (EP) Reference Standard
Nandrolone decanoate, United States Pharmacopeia (USP) Reference Standard
NCGC00159403-02
NCGC00159403-04
NCGC00263561-01
ndrolone-D
Norandrostenolone decanoate
Nortestosterone decanoate
Palactin
PL000379
Retabolil
Retabolyl
Rougerol
Salistoperm
SCHEMBL27975
Superbolan
Tox21_111638
Tox21_111638_1
UNII-H45187T098
ZINC8214619
Ziremilon

US Patents and Regulatory Information for DECA-DURABOLIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aspen Global Inc DECA-DURABOLIN nandrolone decanoate INJECTABLE;INJECTION 013132-001 Jun 12, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aspen Global Inc DECA-DURABOLIN nandrolone decanoate INJECTABLE;INJECTION 013132-002 Jun 12, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aspen Global Inc DECA-DURABOLIN nandrolone decanoate INJECTABLE;INJECTION 013132-003 Jun 12, 1986 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Covington
Harvard Business School
Johnson and Johnson
US Department of Justice
Cantor Fitzgerald
Federal Trade Commission
Merck
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.